CAP-7.1 T26943
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
CAP-7.1, a DNA topoisomerase inhibitor, is used potentially for the treatment of biliary cancer and non-small cell lung cancer.
CAS nr:
433304-61-1
Purity:
98%
Molecular Weight:
746,71
SMILES:
O=C(OC1=C(OC)C=C([C@H]2[C@]3([H])[C@@](COC3=O)([H])[C@H](O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO5)O4)OC5C)O)O)C6=C2C=C7OCOC7=C6)C=C1OC)OCC8OC(C)(C)OC8
Formula:
C36H42O17
Pathway:
Target:
